TotalSeq™-A0084 anti-human CD56 (NCAM) Recombinant Antibody anti-CD56 - QA17A16,BioLegend,392421

Host

Mouse

Reactivity

Human

Application

PG -Quality tested

Platform ID

BAB374943143

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

BioLegend

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NameTotalSeq™-A0084 anti-human CD56 (NCAM) Recombinant Antibody anti-CD56 - QA17A16
Cat. No.392421
HostMouse
RRIDAB_2734445 (BioLegend Cat. No. 392421)
IsotypeMouse IgG1, κ
ReactivityHuman
ApplicationPG -Quality tested
ClonalityRecombinant
Clone NumberQA17A16
Concentration0.5 mg/ml
TargetCD56
PurityThe antibody was purified by chromatography and conjugated with TotalSeq™-A oligomer under optimal conditions.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and EDTA
StorageThe antibody solution should be stored undiluted between 2°C and 8°C. Do not freeze.
Regulatory StatusResearch Use Only

Scientific Background

CD56 is a single transmembrane glycoprotein also known as NCAM (Neural Cell Adhesion Molecule), Leu-19, or NKH1. It is a member of the Ig superfamily. The 140 kD isoform is expressed on NK cells and NK-T cells. CD56 is also expressed in the brain (cerebellum and cortex) and at neuromuscular junctions. Certain large granular lymphocyte (LGL) leukemias, small-cell lung carcinomas, neuronal derived tumors, myelomas, and myeloid leukemias also express CD56. CD56 plays a role in homophilic and heterophilic adhesion via binding to itself or heparin sulfate.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.